Utah Medical Products's biggest risks in the FY2025 10-K
- Regulatory demands and healthcare bureaucracy threaten UTMD’s costs, revenue, management focus, and competitive position as a small device maker.
- GPO purchasing practices may commoditize UTMD’s safety-focused devices and restrict hospital access.
- Distributor dependence, foreign-currency movements, trade restrictions, product liability, and key-person losses create operational and financial exposure.
The risks most specific to Utah Medical Products
Regulatory burdens may result in significant loss of revenue, unpredictable costs and loss of management focus on developing and marketing products that improve the quality of healthcare
FDA and other regulatory demands may delay products, increase costs, reduce revenue, and divert management from developing and marketing devices.
GPOs add non-productive costs, weaken the Company’s marketing and sales efforts and cause lower revenues by restricting access
GPOs may treat UTMD’s patient-safety devices as commodities, restrict hospital access, and pressure revenue while adding non-productive costs.
A product liability lawsuit could result in significant legal expenses and a large award against the Company
A lawsuit involving a device used in a risky medical situation could generate substantial legal expenses or damages after permanent injury.
Third party distributors
Distributors in some markets may produce unpredictable revenue because they vary in expertise and also sell competing or unrelated devices.
The loss of one or more key employees
Losing or distracting key employees could disrupt this small company, while benefits programs are important for recruiting and retention.
Fluctuations in foreign currency exchange (FX) rates relative to the USD
Foreign-currency sales expose reported revenue to a stronger dollar, while a weaker dollar raises foreign-subsidiary operating costs.
Foreign trade restrictions
Geopolitical retaliation, tariffs, duties, or other trade restrictions could disrupt UTMD’s supply chain and significantly increase costs.
All 10 risk factors
Headings as the filing states them, in filing order.
Other
- 01Legislative or executive order healthcare interference in the United States
- 02Regulatory burdens may result in significant loss of revenue, unpredictable costs and loss of management focus on developing and marketing products that improve the quality of healthcare
- 03GPOs add non-productive costs, weaken the Company’s marketing and sales efforts and cause lower revenues by restricting access
- 04The Company’s business strategy
- 05Bureaucracy in healthcare
- 06A product liability lawsuit could result in significant legal expenses and a large award against the Company
- 07Third party distributors
- 08The loss of one or more key employees
- 09Fluctuations in foreign currency exchange (FX) rates relative to the USD
- 10Foreign trade restrictions
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.